Home Biosimilar Antibodies Others Others antibody Foravirumab (Anti-Rabies virus GP) For research use only.
Not for use in humans.

Foravirumab (Anti-Rabies virus GP)

Synonyms: CR4098

Foravirumab (Anti-Rabies virus GP) is a monoclonal antibody targeting rabies virus glycoprotein antigenic site III. It is suitable in treatment of rabies postexposure prophylaxis. MW :144.44 KD.

Foravirumab (Anti-Rabies virus GP)

Purity & Quality Control

Batch: A312501 Purity: 99% Protein concentration: 17.35mg/ml Endotoxin Level: ＜1EU/mg
99

Biological Activity

Description Foravirumab (Anti-Rabies virus GP) is a monoclonal antibody targeting rabies virus glycoprotein antigenic site III. It is suitable in treatment of rabies postexposure prophylaxis. MW :144.44 KD.

Product Details

CAS No. 944548-38-3
Isotype Human IgG1
Source CHO
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Foravirumab (Anti-Rabies virus GP) | Foravirumab (Anti-Rabies virus GP) supplier | purchase Foravirumab (Anti-Rabies virus GP) | Foravirumab (Anti-Rabies virus GP) cost | Foravirumab (Anti-Rabies virus GP) manufacturer | order Foravirumab (Anti-Rabies virus GP) | Foravirumab (Anti-Rabies virus GP) distributor